Correspondence 0001171843-24-004886 from Axe Compute Inc. (AGPU)
Axe Compute Inc.
Date: Aug. 21, 2024 · CIK: 0001446159 · Accession: 0001171843-24-004886
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281579
Letter
PREDICTIVE ONCOLOGY INC.
91 43rd Street, Suite 110
Pittsburgh, PA 15201
August 21, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Jane Park, Staff Attorney
Re: Predictive Oncology Inc.
Acceleration Request for Registration Statement on Form S-3, as amended
File No. 333-281579
Requested Date: August 23, 2024
Requested Time: 4:05 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-281579) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request (the “Registration Statement Acceleration Request”) via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). The Registrant hereby authorizes Alan Seem of DLA Piper LLP (US), counsel for the Registrant, to make such request on the Registrant’s behalf.
The Registrant acknowledges that the Registrant and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
We request that we be notified of the effectiveness of the Registration Statement by telephone to Alan Seem of DLA Piper LLP (US) at 650-833-2050. Thank you for your assistance.
Very truly yours,
/s/ Raymond Vennare
Show Raw Text
CORRESP
1
filename1.htm
PREDICTIVE ONCOLOGY INC.
91 43rd Street, Suite 110
Pittsburgh, PA 15201
August 21, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Jane Park, Staff Attorney
Re:
Predictive Oncology Inc.
Acceleration Request for Registration Statement on Form S-3, as amended
File No. 333-281579
Requested Date: August 23, 2024
Requested Time: 4:05 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933,
as amended, Predictive Oncology Inc. (the “Registrant”) hereby requests that the above-referenced Registration
Statement on Form S-3 (File No. 333-281579) (the “Registration Statement”) be declared effective at the “Requested
Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Registrant
or its counsel may orally request (the “Registration Statement Acceleration Request”) via telephone call to
the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the
“Commission”). The Registrant hereby authorizes Alan Seem of DLA Piper LLP (US), counsel for the Registrant,
to make such request on the Registrant’s behalf.
The Registrant acknowledges that the Registrant and
its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff.
We request that we be notified of the effectiveness of the Registration
Statement by telephone to Alan Seem of DLA Piper LLP (US) at 650-833-2050. Thank you for your assistance.
Very truly yours,
/s/ Raymond Vennare
Raymond Vennare
Chief Executive Officer
cc:
Raymond Vennare (Chief Executive Officer, Predictive Oncology Inc.)
Josh Blacher (Interim Chief Financial Officer, Predictive Oncology Inc.)
Alan Seem (DLA Piper LLP (US))